ASSESSMENT OF ADVERSE DRUG REACTIONS ON CARDIOVASCULAR DRUGS IN HOSPITALIZED PATIENTS OF A TERTIARY CARE HOSPITAL – A PROSPECTIVE ANALYSIS

Author:

DINAKARAN AISHWARYA,RAO PENAKALAPATI SAILAJA,KHANAM QURRATUL AIN,SULTAN SANA,FATHIMA UMAIMA,UDDIN MOHAMMED AZHAR

Abstract

Objective: The present study was taken up to assess the adverse drug reactions (ADRs) based on the spontaneous reactions among the inpatients who were hospitalized for the treatment of cardiac ailments. Methods: A prospective and observational study was done in the department of cardiology for a period of 6 months. Patients on cardiac drug therapy were evaluated to detect unwanted effects and were given treatment for the developed complications. The ADRs were identified, followed up, and documented. Results: In the present study, 255 inpatients were assessed to pinpoint the negative effects and about 80 (n=80) sufferers were recognized with 28 types of ADRs. The highest percentage of ADRs was in adults of age group 60–70 years. Type A accounted for most of the reports which was based on severity. The number of ADRs in heart muscle disorders was found to be 44% (n=35) followed by coronary artery disease 40% (n=32), then heart valve disorders and patients underwent surgery were affiliated to 8% (n=6) each. The highest number of ADRs was reported in patients suffered from disorders pertained to heart muscle. Majority of ADRs were rated as possible, preventable, and moderate according to causality, preventability, and severity parameters, respectively. The data were tabulated, analyzed, and subjected to statistics using Graph Pad Prism 8. Conclusion: It was concluded that proper management and monitoring of drug therapy are the key to prevent ADRs.

Publisher

Innovare Academic Sciences Pvt Ltd

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference19 articles.

1. Gupta M, Kharb P, Kalaiselvan V, Shridhar M, Singh GN, Kshirsagar N, et al. Safety of medicines: Pharmacovigilance programme of India. WHO Drug Inform 2018;32:10-7.

2. WHO Media Centre. Fact Sheet: Cardiovascular Diseases (CVDs); 2016. Available from: https://www.who.int/mediacentre/factsheets/ fs317/en [Last accessed on 2016 Oct 27].

3. Hadi MA, Neoh CF, Zin RM, Elrggal ME, Cheema E. Pharmacovigilance: Pharmacists’ perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract 2017;6:91-8. doi: 10.2147/IPRP.S105881

4. Siddarama R, Bharath Naidu J, Joshisree KP, Sahithi Lakshmi V. Polypharmacy induced drug interactions, adverse drug reactions (ADR) and medication errors in tertiary care south Indian hospital. Int J Pharm Pharm Sci 2019;11:83-93.

5. Sriram S, Ghasemi A, Ramasamy R, Devi M, Balasubramanian R, Ravi TK, et al. Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci 2011;16:16-25.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3